Tandem Diabetes Care (TNDM) Inventory Average (2014 - 2026)

Tandem Diabetes Care's Inventory Average history runs 13 years deep, the most recent figure standing at $127.6 million for Q1 2026.

• Quarterly Inventory Average fell 12.25% year-over-year to $127.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.6 million (down 12.25% YoY) and the FY2025 annual result came in at $139.2 million, down 9.48% from the prior year.
• Inventory Average was $127.6 million for Q1 2026 at Tandem Diabetes Care, down from $133.0 million in the prior quarter.
• Across five years, Inventory Average topped out at $157.8 million in Q2 2024 and bottomed at $74.3 million in Q1 2022.
• A 5-year average of $131.1 million and a median of $139.9 million in 2025 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average soared 66.08% — and 2026, when it declined 12.25%.
• Tandem Diabetes Care's Inventory Average stood at $107.9 million in 2022, then surged by 39.62% to $150.7 million in 2023, then increased by 0.21% to $151.0 million in 2024, then retreated by 11.92% to $133.0 million in 2025, then retreated by 4.09% to $127.6 million in 2026.
• Business Quant data shows TNDM's Inventory Average at $127.6 million in Q1 2026, $133.0 million in Q4 2025, and $139.9 million in Q3 2025.